»Oliver Plumb

About Oliver Plumb

This author has not yet filled in any details.
So far Oliver Plumb has created 39 blog entries.

Irwin Mitchell Joins Group B Strep Support’s Legal Panel

National charity Group B Strep Support and leading law firm, Irwin Mitchell, are delighted to announce their new corporate partnership to raise greater awareness of group B Strep, and provide support to families affected by it. Group B Strep is the most common cause of life-threatening infection in newborn babies, causing meningitis, sepsis or pneumonia in more than 700 babies a year in the UK. On average, two babies a day develop group B Strep infection, one baby a week dies from group B Strep infection and another survives with life-changing disability. Although home testing kits are available to buy for £40, Irwin Mitchell has been backing calls from Group B Strep Support to make the ‘gold standard’  test [...]

By | 2017-03-07T15:20:38+00:00 March 7th, 2017|Latest News|0 Comments

My little boy had late-onset GBS infection

I had the GBS screening during pregnancy and tested negative (Mum lives in Australia where GBS screening is routine in 5 of the 6 states). I then had a hugely traumatic birth. 48-hour labour forceps delivery and my baby ended up with 2 skull fractures and intracranial bleeding, which he fully recovered from. I thought after getting him home from the children's hospital everything would be fine… how wrong I was. At 25 days’ old my baby began to cry inconsolably. After 3 hours, we knew something was very wrong. At the hospital, they suspected meningitis. His entire face and neck swelled up and he was failing right in front of us. I was so scared that we would [...]

By | 2017-02-05T12:12:17+00:00 February 5th, 2017|Baby fully recovered from GBS infection|0 Comments

Biotech company MinervaX announces positive results from Phase 1 GBS vaccine trials

MinervaX, a privately held Danish biotech company, today (5th January) announced positive results from a Phase I trial in 240 healthy adult women with its protein-only GBS vaccine, targeting pregnant women for the prevention of life-threatening infections in newborns. “We are delighted that MinervaX is developing a group B Strep vaccine. Group B Strep is the most common cause of severe infection in newborn babies and of meningitis in babies under 3 months, although most of these infections could be prevented. Despite the UK’s risk-based prevention strategy, the rates of these infections have increased for more than a decade. A safe and effective vaccine is the ‘holy grail’ of GBS prevention and could protect more babies from GBS [...]

By | 2017-01-05T15:12:43+00:00 January 5th, 2017|Latest News|0 Comments

New partnership with HiberGene Diagnostics

Group B Strep Support is delighted to announce a partnership with healthcare company HiberGene Diagnostics to help pregnant women to test for group B Strep – the most common cause of life-threatening infection in newborn babies. One in four pregnant women is unknowingly carrying group B Strep bacteria, which causes meningitis, sepsis or pneumonia in more than 500 newborn babies a year. On average, one newborn baby a week dies from group B Strep infection. Testing for Group B Streptococcus (group B Strep or GBS) is not routinely available through the NHS, unlike countries such as the USA, France, Germany, Poland and many others. HiberGene Diagnostics’ test for GBS is called Strepelle and uses the international ‘gold standard’ Enriched [...]

By | 2017-01-05T13:29:05+00:00 January 5th, 2017|Latest News|0 Comments

Sir Nicholas Soames – Welcome & introduction

Sir Nicholas Soames MP, Patron of Group B Strep Support, opened the conference by articulating the charity's over-arching objective: "To reduce preventable GBS infection in babies. Save infant lives, prevent disability and prevent pain and suffering. To support and inform families affected with GBS and educated health professionals..." Sir Nicholas called on delegates to listen to the discussions closely and carefully, with an open mind. Click here to read the transcript

By | 2016-06-15T14:00:56+00:00 June 15th, 2016|2015 GBS Conference|0 Comments

Dr Alison Bedford Russell – Overview of neonatal group B Streptococcal (GBS) disease

Dr Alison Bedford Russell described how clinical presentations of group B Strep were different between early-onset and late-onset. For example, group B Strep meningitis was more common in late-onset than early-onset GBS infection, while pneumonia was the reverse. Focal infection (infection in a particular area of the body) was "very,very rare" when it came to early-onset, and less rare for late-onset, for example, septic arthritis. Overall, generalised sepsis was the most common presentation. Dr Bedford Russell highlighted some of the difficulties of identifying early-onset GBS infection and also spoke of an increase in newborns presenting with "hypoxic ischemic encephalopathy" also referred to as HIE, a type of brain damage. The number of deaths as a result of group B Strep infection [...]

By | 2016-06-15T13:59:46+00:00 June 15th, 2016|2015 GBS Conference|0 Comments

Dr Catherine O’Sullivan – The burden of invasive GBS disease in young infants in the UK & Republic of Ireland 2014-2015

Dr Catherine O'Sullivan presented a comprehensive analysis of 817 cases of invasive group B Strep in infants under 90 days old, where the samples were drawn from sterile sites such as blood culture or spinal fluid. "In looking from 2014 to 2015, again preliminary, but what we have at the moment, we have an incidence of 0.89 per 1,000 live births which is an increase from 2000-2001 where it was 0.72. Also in those 14-15 years we have seen increased incidence across all countries." Click here to read the transcript Click here to view the slides

By | 2016-06-15T13:58:08+00:00 June 15th, 2016|2015 GBS Conference|0 Comments

Dr Theresa Lamagni – Epidemiology of adult and infant GBS disease in England & Wales

Dr Theresa Lamagni focussed on the epidemiology of invasive group B Strep disease across all age groups from 1991 onwards, using data from Public Health England Laboratory reports between 1991 and 2014. There was a more in-depth focus on 2014 using this data supplemented with Hospital Episode Statistics data and NHS demographic batch tracing. Dr Lamagni observed that there had not been the hoped-for drop in the incidence of GBS disease following the Royal College of Obstetricians and Gynaecologists guidelines at the end of 2003. "The rates of early-onset and late-onset disease have not decreased since the introduction of prevention guidelines and that's really quite disappointing." Click here to read the transcript Click here to view the [...]

By | 2016-06-15T13:57:34+00:00 June 15th, 2016|2015 GBS Conference|0 Comments

Prof Philip Steer – GBS prevention strategies – UK & International (risk based, screening and vaccination)

Prof Philip Steer considered the two major approaches to preventing group B Strep infection in newborn babies: one based on antenatal screening and the other based on identification of risk factors during pregnancy. Identification of risk factors is the approach currently recommended by the Royal College of Obstetricians and Gynaecologists (RCOG) and in use in the UK. "The risk factor approach is very inconsistent - it's very confusing for professionals and certainly for women at large." Click here to read the transcript Click here to view the slides

By | 2016-06-15T13:56:32+00:00 June 15th, 2016|2015 GBS Conference|0 Comments

Prof Alan Cameron – UK NSC GBS screening policy and review

Prof Alan Cameron set out the UK National Screening Committee's (NSC) current policy position on antenatal screening for GBS carriage (2012): Routine screening for GBS carriage in late pregnancy for all pregnant women is currently not recommended in the UK. There was insufficient evidence that benefits gained from screening all women in late pregnancy and treating those women with confirmed GBS carriage by intravenous antibiotics during labour outweigh harm. The next review by the National Screening Committee is due in 2015/16. "We certainly feel that more evidence is needed about the care received by women to refine national policy in the prevention of early-onset GBS infection, to standardise local guidelines and to ultimately reduce the incidence of [...]

By | 2016-06-15T13:55:55+00:00 June 15th, 2016|2015 GBS Conference|0 Comments